trandolaprilat   Click here for help

GtoPdb Ligand ID: 6455

Approved drug PDB Ligand
trandolaprilat is an approved drug (FDA (1996))
Compound class: Synthetic organic
Comment: Generated by metabolic conversion of the prodrug trandolapril
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 3
Rotatable bonds 9
Topological polar surface area 106.94
Molecular weight 402.22
XLogP 2.71
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(C(=O)N1C2CCCCC2CC1C(=O)O)NC(C(=O)O)CCc1ccccc1
Isomeric SMILES C[C@@H](C(=O)N1[C@H]2CCCC[C@@H]2C[C@H]1C(=O)O)N[C@H](C(=O)O)CCc1ccccc1
InChI InChI=1S/C22H30N2O5/c1-14(23-17(21(26)27)12-11-15-7-3-2-4-8-15)20(25)24-18-10-6-5-9-16(18)13-19(24)22(28)29/h2-4,7-8,14,16-19,23H,5-6,9-13H2,1H3,(H,26,27)(H,28,29)/t14-,16+,17-,18-,19-/m0/s1
InChI Key AHYHTSYNOHNUSH-HXFGRODQSA-N
No information available.
Summary of Clinical Use Click here for help
Metabolic product of the prodrug trandolapril, an ACE inhibitor for mild to moderate hypertension, improved survival following myocardial infarction, congestive heart failure, and to slow renal disease.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Inhibits the conversion of angiotensin I to angiotensin II, which in turn decreases blood pressure. Also causes an increase in plasma renin activity.